Singapore approves Pfizer and BioNTech’s Covid-19 vaccine

Singapore has approved the Covid-19 vaccine by Pfizer and its German partner BioNTech, and is also awaiting delivery of the first shots by December.

Singapore is the first Asian country to approve the vaccine, Reuters reported. The free vaccines will initially be administered to health workers and the elderly.

The news agency quoted Singapore Prime Minister Lee Hsien Loong as saying in a national broadcast: “My colleagues and I, including the older ones, will vaccinate us soon.

“This shows you, especially seniors like me, that we believe the vaccines are safe.”

Pfizer and BioNTech have also announced additional data from the Phase I / II test of its BNT162b2 Covid-19 vaccine conducted in Germany.

Data have shown that the vaccine elicits a combined adaptive humoral and cellular immune response against SARS-CoV-2 and provides information on the compositional nature of BNT162b2-induced immunity.

BNT162b2 is authorized for emergency use in people aged 16 years or older.

BioNTech CEO and co-founder Ugur Sahin said: “In parallel with working with regulators around the world to make our vaccine available, we will continue to share important data from our ongoing studies with the global scientific community and the public to advance our collective understanding of the underlying vaccine. mechanism of action.

“Although there is widespread consensus that vaccines should induce antibody responses against the virus, experiences from the previous SARS pandemic indicate that CD8 + T-cell responses may be critical to achieving long-term protection.”

Earlier this week, the U.S. Food and Drug Administration (FDA) authorized the emergency use of Pfizer and BioNTech vaccine.

In a separate development, Moderna has concluded an agreement with the Singapore Ministry of Health to deliver its candidate to Covid-19 vaccine, mRNA-1273, to provide a safe and effective vaccine.